🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

545 results for “B.” Clear

  1. Stent

    Rhythm Pharmaceuticals Netherlands B.V.

    Ischemic Heart Disease

    approved other completed

    1 trial

  2. TYRX™ Absorbable Antibacterial Envelope

    Rhythm Pharmaceuticals Netherlands B.V.

    CIED Related Infection

    approved other completed

    1 trial

  3. Use of an Implantable Loop Recorder

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial

  4. Xuebijing

    Rocket Pharmaceuticals B.V.

    Pulmonary Disease, Chronic Obstructive

    approved small molecule active

    1 trial

  5. doxazosin plus tolterodine SR

    Samsung Bioepis NL B.V.

    Overactive Bladder

    approved small molecule completed

    1 trial

  6. early standardised rhythm control

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

  7. iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Bipolar Disorder

    approved small molecule completed

    1 trial

  8. tasimelteon 20 mg capsule

    Vanda Pharmaceuticals Netherlands B.V.

    Non-24-Hour-Sleep-Wake Disorder

    approved small molecule completed

    1 trial

  9. 99mTc-pyrophosphate Scintigraphy

    Alnylam Netherlands B.V.

    Transthyretin Amyloidosis

    other active

    1 trial

  10. Chronotropic Incompetence Diagnostic Algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    other terminated

    1 trial

  11. Clostridium butyricum (live) Tablets(Meiya)

    Rocket Pharmaceuticals B.V.

    Rectal Cancer

    mab active

    1 trial

  12. Ipilimumab

    Iovance Biotherapeutics B.V.

    Metastatic Melanoma

    small molecule completed

    1 trial

  13. Lidocaine IV

    Samsung Bioepis NL B.V.

    Colorectal Cancer

    small molecule completed

    1 trial

  14. POHIM-RT

    Samsung Bioepis NL B.V.

    Cervix Cancer

    other active

    1 trial

  15. Placebo (for Motilitone)

    Samsung Bioepis NL B.V.

    Dyspepsia

    small molecule completed

    1 trial

  16. SSRI treated group

    Samsung Bioepis NL B.V.

    Depression

    small molecule active

    2 trials

  17. Virtual Reality (VR) Contrast Function Test

    Apellis Europe B.V.

    Age-Related Macular Degeneration

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources